Back
ESC Premium Access

Betablockers in fixed dose combinations: what’s new?

Session: Vasodilating betablockers for our patients. Why to prefer them?
Topic: Pharmacologic therapy
Speaker: Professor G. Mancia (Milan, IT)
Sponsored by MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A.
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Professor Giuseppe Mancia

University of Milan Bicocca, Milan (Italy)
26 presentations
7 followers

1 more presentation in this session

From the selectivity to the clinical and pharmacoeconomic outcomes.

Speaker: Professor F. Messerli (Luzern, CH)

Access
Like
Thumbnail

Access the full session

Vasodilating betablockers for our patients. Why to prefer them?

Speakers: Professor G. Mancia, Professor F. Messerli
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

Related content

ESC Premium Access

Hypertension in stable coronary syndrome - What do the Guidelines say.

31 August 2019

Open Access

Case - Hypertension and diabetes.

1 September 2020

Open Access

Hypertension and diabetes - What do the Guidelines say.

1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources